Celiac.com Sponsor (A1):


Join eNewsletter


Celiac.com Sponsor (A1-m):



Join eNewsletter
  • Join Our Community!

    Ask us a question in our celiac / gluten-free forum.

  • Ayn M Gill

    Is it Celiac or Common Variable Immunodeficiency Disease (CVID)?

    Ayn M Gill
    2 2
    Reviewed and edited by a celiac disease expert.

      Journal of Gluten Sensitivity Autumn 2008 Issue. NOTE: This article is from a back issue of our popular subscription-only paper newsletter. Some content may be outdated.


    Angler Fish mask. Image: CC BY-SA 2.0--Helder da Rocha
    Caption: Angler Fish mask. Image: CC BY-SA 2.0--Helder da Rocha

    Celiac.com 08/13/2020 - If you or someone you know has been diagnosed with celiac disease, you might be familiar with the testing complications that involve patients with IgA deficiency. Generally, many physicians who test patients for celiac disease are unaware that additional testing is required to exclude celiac in patients who are IgA deficient. It stands to reason that physicians might also be unaware of the other immunodeficiency possibilities in patients diagnosed with celiac disease.

    An understanding of the evolution of celiac sprue has come to light over the past several years. The symptoms that have received the greatest emphasis are those that relate to the gastrointestinal tract: malabsorption of nutrients; bloating; diarrhea; abdominal cramping or pain; and small intestinal villous atrophy. Serology testing indicates positive antibodies to gliadin (gluten), the protein in certain grains that damage the small intestine, wheat being most prominent in the United States. As more people have been tested, widely variable results have left patients and physicians at a loss: negative serology, but positive biopsy; positive serology, but negative biopsy; negative serology and biopsy, yet patients continue to suffer. Recently, these variable test results have been thought to be the stage to which the disease has evolved in that patient, i.e., lack of villous atrophy might indicate that celiac has not yet progressed to gastrointestinal damage.



    Celiac.com Sponsor (A12):






    Celiac.com Sponsor (A12-m):




    The gastrointestinal tract is the largest immune organ in the body. As such, it is reasonable to expect that immunodeficiency will impact the gut in some way. Primary immunodeficiency diseases (PIDDs) occur in persons born with an immune system that is either absent or hampered in its ability to function properly. According to the World Health Organization, there are more than 200 primary immunodeficiency diseases. Two of the more common of these immunodeficiency diseases are IgA deficiency and common variable immunodeficiency disease (CVID). Both of these PIDDs are referred to as hypogammaglobulinemias. For the purpose of this article, I will refer to CVID as inclusive of IgA deficiency.  

    Another way to look at PIDDs is to remember that they are primary antibody deficiencies. In spite of their deficiencies, each exhibit variable autoimmune manifestations. Though immunodeficiency and autoimmunity seem to be on opposite sides of the clinical immune response, they are frequently related and can coexist (1,2). Most immunodeficiency diseases are not diagnosed until the third or fourth decade of life. Patients with CVID exhibit poor specific antibody responses and multiple bacterial infections, primarily involving the sinopulmonary tract; however, they also share many of the same GI symptoms seen in celiac sprue. These sprue-like manifestations have given rise to the terms hypogammaglobulinemic sprue, CVID sprue, or IgA sprue. The autoimmune diseases most frequently seen in the hypogammaglobulinemias are autoimmune hematological disease, autoimmune diseases of the gastrointestinal tract, autoimmune endocrine diseases, and autoimmune rheumatic disease. While there is a large body of literature attesting to autoimmune diseases found in immunocompromised patients, exactly how this occurs was not elucidated (3).

    CVID is characterized by a number of gastrointestinal lesions that can mimic other conditions, such as celiac sprue, pernicious anemia, and inflammatory bowel disease, but show significant differences on the microscopic level. In a review study conducted by J.A. Daniels, et al., Johns Hopkins Hospital, Baltimore, MD (4), 132 biopsy and clinical documents on 20 CVID patients over a 26-year period were analyzed. Biopsy and resection samples showed patterns of lymphocytic gastritis, lymphocytic colitis, ulcerative or Crohn colitis, entercolitis, inflammatory bowel disease and villous blunting. In fact, 25% of the patients had a prior diagnosis of celiac disease. Microscopically, however, nearly all of the biopsies lacked plasma cells. In conclusion, this study noted that a diagnosis of CVID might be suspected on the basis of a paucity of plasma cells in a GI biopsy, but because that feature is present in only about two-thirds of patients, other clinical and laboratory evidence is required to make a definite diagnosis.

    Did a gastroenterologist or immunologist conduct that study? Many autoimmune disorders may dominate the clinical picture of PIDDs so that the underlying immunodeficiency is overlooked. The basis of treatment for PIDDs is immunoglobulin replacement for antibody deficiency syndromes (other than selective IgA deficiency) and to prevent and treat infections. Immunoglobulin replacement is also currently being used to treat many autoimmune diseases. The gastrointestinal manifestations of PIDDs are histologically similar to celiac disease; however, serology markers are typically absent, not only in IgA deficiency patients, but also in PIDD patients (5). Treatment for PIDD gastrointestinal lesions is to adhere to a strict gluten free diet, yet resolution of symptoms is not always successful; gastritis, gastroenteritis, colitis, bloating, and wasting from malnutrition are frequent in PIDD patients, despite following a gluten-free diet.

    In summary, the issue of overlapping symptoms and manifestations between celiac disease and primary immunodeficiency diseases is a complicated one. According to some immunologists, PIDD patients exhibit a “sprue-like” disease of the gastrointestinal tract, but not true celiac disease, perhaps due to the lack of serology markers; other immunologists believe PIDD patients do have celiac disease. Most gastroenterologists are unaware of the relationship between autoimmune diseases and immunodefiency and, therefore, miss seeing the complete picture in some patients. There are genetic tests for both celiac disease and immunodeficiency. Is genetic testing the only way to tell for sure if it’s celiac? Or is it simply a matter of education and a closer working relationship between gastroenterologists and immunologists?

    References:

    1. Pavic M, Seve P, Malcus C, Sarrot-Reynault F, Peyramond D, Debourdeau P, Andriamanantena D, Bouhour D, Philippe N, Rousset H, Broussolle C. [Common variable immunodeficiency with autoimmune manifestations: study of nine cases; interest of a peripheral B-cell compartment analysis in seven patients. Rev Med Interne. 2005 Feb;26(2):95-102.
    2. Tanus T, Levinson AI, Atkins PC, Zweiman B. Polyautoimmune syndrome in common variable immunodeficiency. J Intern Med. 1993 Nov;234(5):525-7.
    3. Santaella ML, Cox PR, Colon M, Ramos C, Disdier OM. Rheumatologic manifestations in patients with selected primary immunodeficiencies evaluated at the University Hospital. P R Health Sci J. 2005 Sep;24(3):191-5.
    4. Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007 Dec;31 (12): 1800-12.
    5. Bili H, Nizou C, Nizou JY, Coutant G, Schmoor P, Algayres JP, Daly JP. [Common variable immunodeficiency and total villous atrophy regressive after gluten-free diet] Rev Med Interne. 1997;18(9):724-6.
       
    2 2

    User Feedback

    Recommended Comments

    I had the gene test for celiac and have both DQs. I also tested positive for hereditary alpha tryptasemia and mast cell activation disease. I also have high anti-ccp which have the doctor leaning toward RA and MS. These are all related to the immune system.  Since Celiac disease is body wide but mostly affecting the GI tract,  I wonder if it contributed to the other diseases I have.

    Share this comment


    Link to comment
    Share on other sites

    Celiac Disease has long fingers, often causing neurological problems and it almost always causes dysfunction in the immune system because of "leaky gut". It is also common for celiacs to develop other autoimmune diseases. Many of the same genes are involved between celiac disease and other autoimmune conditions, e.g. diabetes. 

    Share this comment


    Link to comment
    Share on other sites


    Join the conversation

    You are posting as a guest. If you have an account, sign in now to post with your account.
    Note: Your post will require moderator approval before it will be visible.

    Guest
    Add a comment...

    ×   Pasted as rich text.   Restore formatting

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • About Me

    Ayn lives in north Alabama and works as a project manager for an engineering consultant. Born and raised in Kansas, Alabama was a big change for her. Instead of gently rolling hills and big snows, she’s surrounded by mountains and a slower way of life without snow. Ayn spends much of her leisure time walking in the mountains and taking photographs of the wildlife. As the daughter of a physician, medicine has been a lifelong research interest and she hopes to see a treatment for celiac sprue soon.


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-m):




  • Related Articles

    Jefferson Adams
    Celiac.com 02/01/2016 - Among celiac researchers, there's been a good deal of professional curiosity about the clinical and immunological relevance of anti-neuronal antibodies in celiac disease with neurological manifestations. At present, doctors don't know very much about the clinical and immunological features in celiac disease patients with neurological problems, and many of them want to know more.
    Researchers estimate that about 10% of celiac disease patients have neurological issues, with the majority of those suffering from anti-neuronal antibodies (NA) to central nervous system (CNS) and/or anti-neuronal antibodies to the enteric nervous system...

    Jefferson Adams
    Celiac.com 02/08/2016 - When doctors talk about non-celiac gluten sensitivity (NCGS), they are usually talking about people who have gastrointestinal symptoms without enteropathy, and for whom a gluten-free diet (GFD) provides some relief of symptoms.
    However, doctors don't currently know very much about the pathophysiology of NCGS, its connection to neurological manifestations, or if it is in any way different from the manifestations seen in patients celiac disease. To address this issue, a team of researchers recently set out to take a closer look at the clinical and immunological characteristics of patients presenting with neurological manifestations...

    Jefferson Adams
    Celiac.com 10/13/2017 - Tissue transglutaminase (tTG) immunoglobulin A (IgA) testing is a sensitive adjunct to the diagnosis of coeliac disease. The threshold for positivity was developed for diagnosis, with negative results reported as below the reference value (<4 U/mL).
    A team of researchers recently set out to investigate if an undetectable tissue transglutaminase IgA antibodies (tTG IgA<1.2 U/mL) is more predictive of healing compared to patients with negative but detectable serology (1.2-3.9 U/mL).
    The research team included H. Fang, K. S. King, J. J. Larson, M. R. Snyder, T. T. Wu, M. J. Gandhi, and J. A. Murray. They are variously...

    Jefferson Adams
    Celiac.com 04/30/2019 - Doctors recognize that patients with gluten sensitivity, whether or not they have enteropathy, or even gastrointestinal symptoms, can suffer from a range of debilitating neurological manifestations.
    Researchers Panagiotis Zis and Marios Hadjivassiliou of the Academic Department of Neurosciences, Sheffield Teaching hospitals NHS Trust and University of Sheffield, Royal Hallamshire Hospital, Sheffield, UK, recently published an overview of current literature in an effort to assess the available treatment options for the neurological manifestations of gluten-related disorders, specifically, serologically confirmed gluten sensitivity...